• Subscribe

    Webinars & Whitepapers →

    ▾
  • Xconomy National

  • Xperience
    Tech + Life
      • Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
        Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
      • Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
        Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
      • Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?
        Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?
      • John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
        John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
      • As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle
        As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle
      View More in Xperience ›
  • EXOME
    Biotech + Health
      • Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
        Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
      • Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More
        Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More
      • In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug
        In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug
      • miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
        miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
      • Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
        Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
      View More in EXOME ›
  • Our
    Regions
    • Boston ›
      • In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug
        In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug
      View More in Boston ›
    • Boulder/Denver ›
      • miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
        miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
        Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test
        Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test
      View More in Indiana ›
    • New York ›
      • Amarin's Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
        Amarin's Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
      View More in New York ›
    • Raleigh-Durham ›
      • Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%
        Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%
      View More in Raleigh-Durham ›
    • San Diego ›
      • Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy
        Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy
      View More in San Diego ›
    • San Francisco ›
      • BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs
        BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs
      View More in San Francisco ›
    • Seattle ›
      • A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns
        A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns
      View More in Seattle ›
    • Texas ›
      • Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
        Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
      View More in Texas ›
    • Wisconsin ›
      • AI Can Unlock Health Data's Potential, But Access Is Still Difficult
        AI Can Unlock Health Data's Potential, But Access Is Still Difficult
      View More in Wisconsin ›
  • Tech
    Channels
    • Agtech and Food›
      • The Davis Dilemma: New Energy for Innovation, But Where to Grow?
        The Davis Dilemma: New Energy for Innovation, But Where to Grow?
      View More in Agtech and Food ›
    • Cleantech›
        View More in Cleantech ›
      • Cybersecurity›
          View More in Cybersecurity ›
        • Education›
            View More in Education ›
          • EXOME: Biotech + Health›
            • eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test
              eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test
            View More in EXOME ›
          • Fintech›
              View More in Fintech ›
            • Healthtech›
              • AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
                AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
              View More in Healthtech ›
            • Robotics and A.I.›
              • Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More
                Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More
              View More in Robotics and A.I. ›
            • Startups›
              • AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund
                AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund
              View More in Startups ›
            • Xperience: Tech + Life›
                View More in Xperience ›
            • Meet the
              Xconomists
              • David Baltimore

                David Baltimore

                Nobel Laureate, Professor of Biology, Caltech

              • Andy Palmer

                Andy Palmer

                CEO and Co-Founder, Tamr

              • Alexandra Wilkis Wilson

                Alexandra Wilkis Wilson

                Founder, Gilt Groupe

              • C. Titus Brown

                C. Titus Brown

                Professor, Michigan State University

              • Meet All the Xconomists ›
              • Ben Elowitz

                Ben Elowitz

                Co-Founder and CEO, Wetpaint

              • Andy Palmer

                Andy Palmer

                CEO and Co-Founder, Tamr

              • Alexis Borisy

                Alexis Borisy

                Partner, Third Rock Ventures

              • Elizabeth Hagerman

                Elizabeth Hagerman

                Vice President for Corporate Engagement, Rose-Hulman Institute of Technology

            • Our
              Events
              • All Xconomy Events › Boston Events ›
              • Boulder/Denver Events › Detroit/Ann Arbor Events ›
              • Indiana Events › New York Events ›
              • Raleigh-Durham Events ›San Diego Events ›
              • San Francisco Events ›Seattle Events ›
              • Texas Events › Wisconsin Events ›
            • Xpertise
              Watch + Learn

            “amory-lovins” Archives

            in
            Entry Author Date Location
            Amid Wave of Bioinspiration, San Diego Zoo Creates Innovation Center Bruce V. Bigelow 08/29/12 San Diego
            Cleantech Innovation and ‘Reinventing Fire’ with Amory Lovins Bruce V. Bigelow 04/03/12 San Diego
            Reinventing Fire, An Evening with Amory Lovins-In Photos Erin Kutz 02/22/12 Boston
            Applied Hope Amory Lovins 02/21/12 National
            Hope to See You Tonight for Chat with Amory Lovins-Few Tickets Left Robert Buderi 02/16/12 Boston
            A 2.6X Economy with No Oil, Coal, or Nukes: Amory Lovins Explains on 2/16 Robert Buderi 02/13/12 Boston
            Finding Another Saudi Arabia Under Detroit: Amory Lovins on the Economic Logic of Energy Efficiency and the Overthrow of Bad Engineering Wade Roush 12/08/08 Boston
            Re-energizing Energy Innovation: Experts Spar (Lightly) at Xconomy Forum Wade Roush 12/04/08 Boston
            An Energetic Thank You to Our Energy Innovation Forum Speakers and Sponsors Robert Buderi 12/03/08 Boston
            Xconomy Closes Second Financing Round Robert Buderi 11/25/08 National
            Last Call on Registration and First Call on Presentations for Xconomy Forum on Energy Innovation Robert Buderi 11/14/08 Boston
            Page 1 of 1

            Underwriters and Partners

            Xpertise: Watch + Learn
            • What to Include in Your Life Sciences Company Fundraising Pitch Deck

              Sponsored · Whitepaper

              What to Include in Your Life Sciences Company Fundraising Pitch Deck

              What the most successful life sciences fundraising pitch decks all have in common

              Brex
            • How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

              Xconomy Insight · Special Report

              How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

              Insights, wisdom, and inspiration on what it takes

            • Digitizing 10 Life Sciences Paper Processes

              Sponsored · Whitepaper

              Digitizing 10 Life Sciences Paper Processes

              How to accelerate your life sciences business with every agreement

              DocuSign

            Connect with Xconomy

            • Xconomy on Facebook
            • Xconomy on Twitter
            • Xconomy on Linkedin
            • Xconomy on Google PLus
            • Xconomy Feeds

            Xconomy on Demand

            Did you miss something? Don't despair…

            Xconomy offers a number of ways to subscribe for free!

            Subscribe Now
            IDG Tech Network
            Protected by Carbonite
            Eventbrite - events made easy
            • Home
            • Privacy/DMCA
            • Security Disclosures
            • About
            • Contact Us
            • Archives
            • Advertise
            • Subscribe for Free

            Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

            © 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

            Website development support from Andrew Koyfman with design support from Rob Hunter.